Groups Emphasize Long-Term Focus On Comparative Effectiveness Research
This article was originally published in The Gray Sheet
Executive Summary
High-profile groups of physicians and federal health care officials are calling for hefty investment in a national comparative effectiveness research infrastructure and a long-term strategy to ensure that a robust program can be sustained beyond the two years funded under current law
You may also be interested in...
Data Lacking On Proton Therapy Vs. Traditional Radiation For Cancer - AHRQ
Particle beam radiation - also known as proton therapy - is a "promising" cancer treatment, but potential advantages over alternative radiation therapies remain unproven due to a lack of long-term comparative studies, according to a Sept. 14 Agency for Healthcare Research and Quality technical brief
Data Lacking On Proton Therapy Vs. Traditional Radiation For Cancer - AHRQ
Particle beam radiation - also known as proton therapy - is a "promising" cancer treatment, but potential advantages over alternative radiation therapies remain unproven due to a lack of long-term comparative studies, according to a Sept. 14 Agency for Healthcare Research and Quality technical brief
AHRQ Considers Creating A List Of Patient Registries
As the Agency for Healthcare Research and Quality steps up investment in observational studies, it is seeking public comment on whether to pool patient registries into one big list, a "registry of registries.